| Item Type | Name |
|
Academic Article
|
Plasma concentrations of immunoreactive atrial natriuretic peptide in hospitalized cirrhotic and noncirrhotic patients: evidence for a role of deficient atrial natriuretic peptide in pathogenesis of cirrhotic ascites.
|
|
Concept
|
Virus Diseases
|
|
Concept
|
Autoimmune Diseases
|
|
Concept
|
Liver Diseases
|
|
Concept
|
Demyelinating Diseases
|
|
Concept
|
Bone Diseases, Metabolic
|
|
Concept
|
Viral Nonstructural Proteins
|
|
Concept
|
Bile Duct Diseases
|
|
Concept
|
Chronic Disease
|
|
Concept
|
Genetic Diseases, X-Linked
|
|
Concept
|
Acute Disease
|
|
Concept
|
Genetic Predisposition to Disease
|
|
Concept
|
Disease Management
|
|
Concept
|
Nervous System Diseases
|
|
Concept
|
Statistics, Nonparametric
|
|
Concept
|
Lung Diseases
|
|
Concept
|
Liver Diseases, Alcoholic
|
|
Concept
|
Fatty Liver, Alcoholic
|
|
Concept
|
Peripheral Nervous System Diseases
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Skin Diseases
|
|
Concept
|
Stomach Diseases
|
|
Concept
|
Disease Progression
|
|
Concept
|
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
|
|
Concept
|
Tangier Disease
|
|
Concept
|
Metabolic Diseases
|
|
Academic Article
|
Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools.
|
|
Academic Article
|
Osteocalcin and bone alkaline phosphatase in the serum of women with liver disease.
|
|
Academic Article
|
Prevalence and prediction of osteopenia in chronic liver disease.
|
|
Academic Article
|
Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease.
|
|
Academic Article
|
Choline may be an essential nutrient in malnourished patients with cirrhosis.
|
|
Academic Article
|
The porphyrias.
|
|
Academic Article
|
Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda.
|
|
Academic Article
|
Hepatic heme and drug metabolism in rats with chronic mountain sickness.
|
|
Academic Article
|
Hepatic heme synthesis in a new model of experimental hemochromatosis: studies in rats fed finely divided elemental iron.
|
|
Academic Article
|
Fatal liver failure in protoporphyria. Synergism between ethanol excess and the genetic defect.
|
|
Academic Article
|
Effect of hemochromatosis on hepatic cytochrome P450 and antipyrine metabolism in humans.
|
|
Academic Article
|
High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.
|
|
Academic Article
|
Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy.
|
|
Academic Article
|
A detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C.
|
|
Academic Article
|
Chronic leukocytoclastic vasculitis complicating HBV infection. Possible role of mutant forms of HBV in pathogenesis and persistence of disease.
|
|
Academic Article
|
Putting the freeze on hepatitis C virus-associated mixed cryoglobulinemia.
|
|
Academic Article
|
Colonic mucosal appearance of Tangier disease in a new patient.
|
|
Academic Article
|
Acute hepatic and renal toxicity from low doses of acetaminophen in the absence of alcohol abuse or malnutrition: evidence for increased susceptibility to drug toxicity due to cardiopulmonary and renal insufficiency.
|
|
Academic Article
|
Nutritional supplementation in chronic liver disease: an analytical review.
|
|
Academic Article
|
Mixed cryoglobulinemia in chronic hepatitis C infection. A clinicopathologic analysis of 10 cases and review of recent literature.
|
|
Academic Article
|
Advances in understanding and treating 'the little imitator,' acute porphyria.
|
|
Academic Article
|
Iron and chronic viral hepatitis: emerging evidence for an important interaction.
|
|
Academic Article
|
High-dose interferon-alpha 2b for re-treatment of nonresponders or relapsing patients with chronic hepatitis C. A controlled randomized trial.
|
|
Academic Article
|
Iron in liver diseases other than hemochromatosis.
|
|
Academic Article
|
An update on iron metabolism: summary of the Fifth International Conference on Disorders of Iron Metabolism.
|
|
Academic Article
|
Iron and chronic viral hepatitis.
|
|
Academic Article
|
Utility of hepatic iron index in American patients with hereditary hemochromatosis: a multicenter study.
|
|
Academic Article
|
Inflammatory markers in chronic hepatitis C.
|
|
Academic Article
|
Frequency and distribution of DNA fragmentation as a marker of cell death in chronic liver diseases.
|
|
Academic Article
|
Diagnosis of porphyric syndromes: a practical approach in the era of molecular biology.
|
|
Academic Article
|
Management of acute attacks in the porphyrias.
|
|
Academic Article
|
Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques.
|
|
Academic Article
|
Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.
|
|
Academic Article
|
Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis.
|
|
Academic Article
|
Zebrafish dracula encodes ferrochelatase and its mutation provides a model for erythropoietic protoporphyria.
|
|
Academic Article
|
Hepatitis C: a review and update.
|
|
Academic Article
|
Iron-induced liver injury.
|
|
Academic Article
|
Ubiquitin as a marker of cell injury in nonalcoholic steatohepatitis.
|
|
Academic Article
|
Extrahepatic manifestations of infection with hepatitis C virus.
|
|
Academic Article
|
Management of nonalcoholic steatohepatitis: an analytic review.
|
|
Academic Article
|
Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C.
|
|
Academic Article
|
Optimal management of nonalcoholic fatty liver/steatohepatitis.
|
|
Academic Article
|
Iron as a co-morbid factor in nonhemochromatotic liver disease.
|
|
Academic Article
|
Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.
|
|
Academic Article
|
Hemochromatosis mutations in Iranians with hepatitis B virus infection.
|
|
Academic Article
|
Iron in nonhemochromatotic liver disorders.
|
|
Academic Article
|
Liver transplantation for erythropoietic protoporphyria liver disease.
|
|
Academic Article
|
Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C.
|
|
Academic Article
|
Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
|
|
Academic Article
|
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.
|
|
Academic Article
|
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.
|
|
Academic Article
|
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
|
Academic Article
|
Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes.
|
|
Academic Article
|
Vascular endothelium as a contributor of plasma sphingosine 1-phosphate.
|
|
Academic Article
|
Case records of the Massachusetts General Hospital. Case 20-2008. A 57-year-old woman with abdominal pain and weakness after gastric bypass surgery.
|
|
Academic Article
|
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
|
|
Academic Article
|
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.
|
|
Academic Article
|
Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.
|
|
Academic Article
|
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
|
|
Academic Article
|
The neuromediator glutamate, through specific substrate interactions, enhances mitochondrial ATP production and reactive oxygen species generation in nonsynaptic brain mitochondria.
|
|
Academic Article
|
Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
|
Academic Article
|
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
|
|
Academic Article
|
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.
|
|
Academic Article
|
Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial.
|
|
Academic Article
|
Drug-induced liver injury associated with statins.
|
|
Academic Article
|
Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.
|
|
Academic Article
|
Zinc mesoporphyrin induces rapid proteasomal degradation of hepatitis C nonstructural 5A protein in human hepatoma cells.
|
|
Academic Article
|
Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C.
|
|
Academic Article
|
Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.
|
|
Academic Article
|
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.
|
|
Academic Article
|
Outcome of sustained virological responders with histologically advanced chronic hepatitis C.
|
|
Academic Article
|
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.
|
|
Academic Article
|
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C.
|
|
Academic Article
|
Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis C.
|
|
Academic Article
|
Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C.
|
|
Academic Article
|
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.
|
|
Academic Article
|
Legalon-SIL downregulates HCV core and NS5A in human hepatocytes expressing full-length HCV.
|
|
Academic Article
|
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.
|
|
Academic Article
|
microRNAs: fad or future of liver disease.
|
|
Academic Article
|
Lon peptidase 1 (LONP1)-dependent breakdown of mitochondrial 5-aminolevulinic acid synthase protein by heme in human liver cells.
|
|
Academic Article
|
Respiration and ROS production in brain and spinal cord mitochondria of transgenic rats with mutant G93a Cu/Zn-superoxide dismutase gene.
|
|
Academic Article
|
Association of filamin A and vimentin with hepatitis C virus proteins in infected human hepatocytes.
|
|
Academic Article
|
YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C.
|
|
Academic Article
|
Neonatal androgenization exacerbates alcohol-induced liver injury in adult rats, an effect abrogated by estrogen.
|
|
Academic Article
|
Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
|
|
Academic Article
|
Identification of differentially expressed proteins from primary versus metastatic pancreatic cancer cells using subcellular proteomics.
|
|
Academic Article
|
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.
|
|
Academic Article
|
Liver injury from tumor necrosis factor-a antagonists: analysis of thirty-four cases.
|
|
Academic Article
|
Cytoskeletal proteins: shaping progression of hepatitis C virus-induced liver disease.
|
|
Academic Article
|
Loss-of-function ferrochelatase and gain-of-function erythroid-specific 5-aminolevulinate synthase mutations causing erythropoietic protoporphyria and x-linked protoporphyria in North American patients reveal novel mutations and a high prevalence of X-linked protoporphyria.
|
|
Academic Article
|
Chronic hepatitis E with neurologic manifestations and rapid progression of liver fibrosis in a liver transplant recipient.
|
|
Academic Article
|
Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.
|
|
Academic Article
|
Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
|
|
Academic Article
|
Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance.
|
|
Academic Article
|
Hepatotoxicity of anti-TNF agents.
|
|
Academic Article
|
Hepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcome.
|
|
Academic Article
|
Herbal dietary supplement associated hepatotoxicity: an upcoming workshop and need for research.
|
|
Academic Article
|
Herbal products and the liver: a review of adverse effects and mechanisms.
|
|
Academic Article
|
On stress and the liver: a chicken and egg conundrum.
|
|
Academic Article
|
Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis.
|
|
Academic Article
|
Acute Porphyrias.
|
|
Academic Article
|
Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism.
|
|
Academic Article
|
Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.
|
|
Academic Article
|
Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.
|
|
Academic Article
|
Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response.
|
|
Grant
|
Research Network for Drug-Induced Liver Disease
|
|
Grant
|
HEPATITIS C CLINICAL TRIAL-CLINICAL CENTERS
|
|
Grant
|
Effect of Heme on mRNA and miRNA Profile
|
|
Academic Article
|
Clinical, Biochemical, and Genetic Characterization of North American Patients With Erythropoietic Protoporphyria and X-linked Protoporphyria.
|
|
Academic Article
|
Acute hepatic porphyrias: Recommendations for evaluation and long-term management.
|
|
Academic Article
|
miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling.
|
|
Academic Article
|
Peripheral Neuropathy and the Ceruloplasmin Gene.
|
|
Academic Article
|
Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Cav3.2?T-type voltage-gated calcium channels and Ca2+ influx.
|
|
Academic Article
|
Genetic Polymorphisms Implicated in Nonalcoholic Liver Disease or Selected Other Disorders Have No Influence on Drug-Induced Liver Injury.
|
|
Academic Article
|
Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors.
|
|
Academic Article
|
Sex differences in vascular reactivity in mesenteric arteries from a mouse model of acute intermittent porphyria.
|